chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Agitation, Fatigue, Nausea, Pyrexia
Clinical narrative: feeling very fatigued wt a mild fever extremely agitated; feeling very fatigued wt a mild fever extremely agitated; Nauseous and very tired too; feeling very fatigued wt a mild fever extremely agitated; This spontaneous case was reported by a consumer and describes the occurrence of AGITATION (feeling very fatigued wt a mild fever extremely agitated), FATIGUE (feeling very fatigued wt a mild fever extremely agitated), NAUSEA (Nauseous and very tired too) and PYREXIA (feeling very fatigued wt a mild fever extremely agitated) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AGITATION (feeling very fatigued wt a mild fever extremely agitated), FATIGUE (feeling very fatigued wt a mild fever extremely agitated), NAUSEA (Nauseous and very tired too) and PYREXIA (feeling very fatigued wt a mild fever extremely agitated). At the time of the report, AGITATION (feeling very fatigued wt a mild fever extremely agitated), FATIGUE (feeling very fatigued wt a mild fever extremely agitated), NAUSEA (Nauseous and very tired too) and PYREXIA (feeling very fatigued wt a mild fever extremely agitated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       At the time of reporting, the patient stated that they received the Moderns vaccine 8 days ago.  No concomitant product use was provided by the reporter.   No treatment medications were reported.   Reporter did not allow further contact
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Mydriasis, Pyrexia
Clinical narrative: Weakness; Chills; Fever; Dilated Pupils; This spontaneous case was reported by a consumer and describes the occurrence of MYDRIASIS (Dilated Pupils), ASTHENIA (Weakness), CHILLS (Chills) and PYREXIA (Fever) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Relevant Medical history was not provided.  Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    In August 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced MYDRIASIS (Dilated Pupils), CHILLS (Chills) and PYREXIA (Fever). On an unknown date, the patient experienced ASTHENIA (Weakness). At the time of the report, MYDRIASIS (Dilated Pupils), ASTHENIA (Weakness), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not  provided.   Reporter did not allow further contact
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Head discomfort
Clinical narrative: This spontaneous case reported by a nurse, describes the occurrence of head discomfort (complaining of a heavy head) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Aug 31, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced head discomfort (complaining of a heavy head). At the time of the report, head discomfort (complaining of a heavy head) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. The reporter did not provide any causality assessments, concomitant medications or treatment information.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Accidental overdose, Ageusia, Tinnitus
Clinical narrative: A ringing on both ears/ tinnitus; second dose seemed like a larger dose than the first; Lost taste/ barely taste/ He can barely taste coffee, can't taste vinegar/ does not have taste; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Lost taste/ barely taste/ He can barely taste coffee, can't taste vinegar/ does not have taste), TINNITUS (A ringing on both ears/ tinnitus) and ACCIDENTAL OVERDOSE (second dose seemed like a larger dose than the first) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 051C21A and 051C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Aug-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced AGEUSIA (Lost taste/ barely taste/ He can barely taste coffee, can't taste vinegar/ does not have taste). On an unknown date, the patient experienced TINNITUS (A ringing on both ears/ tinnitus) and ACCIDENTAL OVERDOSE (second dose seemed like a larger dose than the first). At the time of the report, AGEUSIA (Lost taste/ barely taste/ He can barely taste coffee, can't taste vinegar/ does not have taste) and TINNITUS (A ringing on both ears/ tinnitus) outcome was unknown and ACCIDENTAL OVERDOSE (second dose seemed like a larger dose than the first) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was reported.  No treatment medications were reported  Patient wants some medical advice over the situation   This case was linked to MOD-2021-305910 (Patient Link).
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Headache, Influenza like illness, Liver function test
Clinical narrative: Periods got heavier ,longer , clots in the flow; Achy; Really bad headache; Felt like she had been hit by tractor trailer; Chills; Flu like symptoms; Coughing; Arm hurt really bad; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Felt like she had been hit by tractor trailer), INFLUENZA LIKE ILLNESS (Flu like symptoms), COUGH (Coughing), PAIN IN EXTREMITY (Arm hurt really bad) and MENSTRUAL DISORDER (Periods got heavier ,longer , clots in the flow) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 031L20A.) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sciatica (Patient takes cortisone injections for her back problem/sciatica. Patient is immunocompromised secondary to receiving the cortisone injections), Morbid obesity, Blood pressure (Patient has high blood pressure), Asthma and Liver disorder. Concomitant products included METOPROLOL SUCCINATE (TOPROL) for Allergy, CORTISONE for Sciatica, LOSARTAN and HYDROCHLOROTHIAZIDE for an unknown indication.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION COMPLICATION (Felt like she had been hit by tractor trailer), INFLUENZA LIKE ILLNESS (Flu like symptoms), COUGH (Coughing), PAIN IN EXTREMITY (Arm hurt really bad), CHILLS (Chills) and HEADACHE (Really bad headache). On 17-Feb-2021, the patient experienced MYALGIA (Achy). In March 2021, the patient experienced MENSTRUAL DISORDER (Periods got heavier ,longer , clots in the flow). At the time of the report, VACCINATION COMPLICATION (Felt like she had been hit by tractor trailer), INFLUENZA LIKE ILLNESS (Flu like symptoms), COUGH (Coughing), PAIN IN EXTREMITY (Arm hurt really bad), MENSTRUAL DISORDER (Periods got heavier ,longer , clots in the flow), CHILLS (Chills), MYALGIA (Achy) and HEADACHE (Really bad headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In August 2021, Liver function test: increased (High) Liver panel drawn shows elevated liver enzymes. Liver panel drawn previously in December was.         Patient says she is trying to decide about taking the 3rd dose as she is at risk. treatment information was not provided   This case was linked to MOD-2021-305846 (Patient Link).
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Menstrual disorder, Myalgia, Pain in extremity, Vaccination complication
Clinical narrative: Periods got heavier ,longer , clots in the flow; Achy; Really bad headache; Felt like she had been hit by tractor trailer; Chills; Flu like symptoms; Coughing; Arm hurt really bad; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Felt like she had been hit by tractor trailer), INFLUENZA LIKE ILLNESS (Flu like symptoms), COUGH (Coughing), PAIN IN EXTREMITY (Arm hurt really bad) and MENSTRUAL DISORDER (Periods got heavier ,longer , clots in the flow) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 031L20A.) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sciatica (Patient takes cortisone injections for her back problem/sciatica. Patient is immunocompromised secondary to receiving the cortisone injections), Morbid obesity, Blood pressure (Patient has high blood pressure), Asthma and Liver disorder. Concomitant products included METOPROLOL SUCCINATE (TOPROL) for Allergy, CORTISONE for Sciatica, LOSARTAN and HYDROCHLOROTHIAZIDE for an unknown indication.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION COMPLICATION (Felt like she had been hit by tractor trailer), INFLUENZA LIKE ILLNESS (Flu like symptoms), COUGH (Coughing), PAIN IN EXTREMITY (Arm hurt really bad), CHILLS (Chills) and HEADACHE (Really bad headache). On 17-Feb-2021, the patient experienced MYALGIA (Achy). In March 2021, the patient experienced MENSTRUAL DISORDER (Periods got heavier ,longer , clots in the flow). At the time of the report, VACCINATION COMPLICATION (Felt like she had been hit by tractor trailer), INFLUENZA LIKE ILLNESS (Flu like symptoms), COUGH (Coughing), PAIN IN EXTREMITY (Arm hurt really bad), MENSTRUAL DISORDER (Periods got heavier ,longer , clots in the flow), CHILLS (Chills), MYALGIA (Achy) and HEADACHE (Really bad headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In August 2021, Liver function test: increased (High) Liver panel drawn shows elevated liver enzymes. Liver panel drawn previously in December was.         Patient says she is trying to decide about taking the 3rd dose as she is at risk. treatment information was not provided   This case was linked to MOD-2021-305846 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Lymphadenopathy, Pyrexia, Rhinorrhoea
Clinical narrative: Runny nose; fever of 101.5; Swollen glands on both sides of throat; Fatigued; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Runny nose), PYREXIA (fever of 101.5), LYMPHADENOPATHY (Swollen glands on both sides of throat) and FATIGUE (Fatigued) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RHINORRHOEA (Runny nose), PYREXIA (fever of 101.5), LYMPHADENOPATHY (Swollen glands on both sides of throat) and FATIGUE (Fatigued). At the time of the report, RHINORRHOEA (Runny nose), PYREXIA (fever of 101.5), LYMPHADENOPATHY (Swollen glands on both sides of throat) and FATIGUE (Fatigued) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.5 (High) Fever of 101.5.         Concomitant medications were not reported by reporter.  Treatment information was not provided by reporter   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Consumer answered yes when asked if they experienced any side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Consumer answered yes when asked if they experienced any side effects) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Consumer answered yes when asked if they experienced any side effects). At the time of the report, VACCINATION COMPLICATION (Consumer answered yes when asked if they experienced any side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported. No treatment information was provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Dyspnoea exertional, Fatigue
Clinical narrative: Almost out of breath after doing simple things; More fatigued than normal; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA EXERTIONAL (Almost out of breath after doing simple things) and FATIGUE (More fatigued than normal) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA EXERTIONAL (Almost out of breath after doing simple things) and FATIGUE (More fatigued than normal). At the time of the report, DYSPNOEA EXERTIONAL (Almost out of breath after doing simple things) and FATIGUE (More fatigued than normal) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  Treatment information was not provided.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Psoriasis
Clinical narrative: His psoriasis has been more pronounced/ increase in the psoriasis in his legs/seems to have continued; This spontaneous case was reported by a consumer and describes the occurrence of PSORIASIS (His psoriasis has been more pronounced/ increase in the psoriasis in his legs/seems to have continued) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 031L20A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE and ALLOPURINOL for an unknown indication.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PSORIASIS (His psoriasis has been more pronounced/ increase in the psoriasis in his legs/seems to have continued). The patient was treated with CLOBETASOL PROPIONATE (CLOBETASOL PROPIONATE E) for Psoriasis aggravated, at a dose of 0.05 percent. At the time of the report, PSORIASIS (His psoriasis has been more pronounced/ increase in the psoriasis in his legs/seems to have continued) outcome was unknown.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Tinnitus
Clinical narrative: Balance problems; ringing in my ears; This spontaneous case was reported by a consumer and describes the occurrence of BALANCE DISORDER (Balance problems) and TINNITUS (ringing in my ears) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019821A and 032M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BALANCE DISORDER (Balance problems) and TINNITUS (ringing in my ears). At the time of the report, BALANCE DISORDER (Balance problems) and TINNITUS (ringing in my ears) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Feeding disorder, Hypokinesia, Mobility decreased, Vaccination complication
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of vaccination complication, hypokinesia (could not move legs or hands and cannot stretch elbows), decreased mobility (cannot get out of bed) and feeding disorder (unable to eat) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. Concurrent medical conditions included immunocompromised. On an unknown date, patient received the third dose of mRNA-1273 (Moderna COVID-19  vaccine), unknown route; 1 dosage form. On an unknown date, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form; and the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced vaccination complication, hypokinesia (could not move legs or hands and cannot stretch elbows), decreased mobility (cannot get out of bed) and feeding disorder (unable to eat). At the time of the report, vaccination complication, hypokinesia (could not move legs or hands and cannot stretch elbows), decreased mobility (cannot get out of bed) and feeding disorder (unable to eat) outcome: unknown. Concomitant drug use and treatment information not reported. Reportedly, patient's physician recommended for her to take the 3rd dose. Patient had two surgeries this year.
Sex: F
Vaccine: COVID19
Symptoms: Fall, Injury, Vertigo
Clinical narrative: severe vertigo; falls; two severe injuries; This spontaneous case was reported by a patient family member or friend and describes the occurrence of VERTIGO (severe vertigo), FALL (falls) and INJURY (two severe injuries) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VERTIGO (severe vertigo), FALL (falls) and INJURY (two severe injuries). At the time of the report, VERTIGO (severe vertigo), FALL (falls) and INJURY (two severe injuries) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment reported.   Reporter did not allow further contact
Age: 62.0
Sex: U
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: got sick for 3 days; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (got sick for 3 days) in a 62-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (got sick for 3 days). At the time of the report, ILLNESS (got sick for 3 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product was not provided by the reporter. Treatment information was not provided.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram, Hypoaesthesia, Magnetic resonance imaging, Nerve injury
Clinical narrative: Whole arm went completely numb,  went to her face and left side of her body, legs are also numb; Nerve damage; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Whole arm went completely numb,  went to her face and left side of her body, legs are also numb) and NERVE INJURY (Nerve damage) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy, Drug allergy (Amoxicillin) and Sulfonamide allergy. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]), VITAMIN C [ASCORBIC ACID], VITAMIN D NOS and ZINC for an unknown indication.    On 01-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Sep-2021, the patient experienced HYPOAESTHESIA (Whole arm went completely numb,  went to her face and left side of her body, legs are also numb) and NERVE INJURY (Nerve damage). At the time of the report, HYPOAESTHESIA (Whole arm went completely numb,  went to her face and left side of her body, legs are also numb) and NERVE INJURY (Nerve damage) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In September 2021, Computerised tomogram: normal (normal) Normal. In September 2021, Magnetic resonance imaging: normal (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications also included Probiotics.  The treatment information was  not provided.  It was reported that patient's ER doctor  was considering nerve damage and  patient will be referred to Neurologist if numbness persist.
Sex: M
Vaccine: COVID19
Symptoms: Illness, Influenza like illness
Clinical narrative: sick a little bit; like a flu for the first 2 days; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick a little bit) and INFLUENZA LIKE ILLNESS (like a flu for the first 2 days) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jul-2021, the patient experienced ILLNESS (sick a little bit) and INFLUENZA LIKE ILLNESS (like a flu for the first 2 days). On 27-Jul-2021, ILLNESS (sick a little bit) and INFLUENZA LIKE ILLNESS (like a flu for the first 2 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant drugs were reported.  No Treatment information  were reported.
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of dyspnea (labored breath/trouble breathing) in a male patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 050C21A) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced dyspnea (labored breath/trouble breathing). At the time of the report, dyspnea (labored breath/trouble breathing) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. Concomitant product use and treatment information not provided. On an unknown date, around 10 or 12 days ago, patient received first dose. On an unknown date, about 10 days ago, symptoms started according to the patient.
Sex: U
Vaccine: COVID19
Symptoms: Myalgia, Rash, Vaccination site pustule, Vaccination site swelling
Clinical narrative: Raised, and has bubbles around it/puffy, watery; Several little pockets of like a flat type of rash/almost like a rash/about one and a half inches long; Bumps around injection site; Sore arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PUSTULE (Raised, and has bubbles around it/puffy, watery), RASH (Several little pockets of like a flat type of rash/almost like a rash/about one and a half inches long), VACCINATION SITE SWELLING (Bumps around injection site) and MYALGIA (Sore arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PUSTULE (Raised, and has bubbles around it/puffy, watery), RASH (Several little pockets of like a flat type of rash/almost like a rash/about one and a half inches long), VACCINATION SITE SWELLING (Bumps around injection site) and MYALGIA (Sore arm). At the time of the report, VACCINATION SITE PUSTULE (Raised, and has bubbles around it/puffy, watery), RASH (Several little pockets of like a flat type of rash/almost like a rash/about one and a half inches long), VACCINATION SITE SWELLING (Bumps around injection site) and MYALGIA (Sore arm) outcome was unknown.            No concomitant medication information was provided.  No treatment medication were provided.   Rash is about one and a half inches long.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pre-existing condition improved, Therapeutic response unexpected
Clinical narrative: Had a positive reaction/it cleared up her lungs and all her respiratory system; Helped with her asthma; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Had a positive reaction/it cleared up her lungs and all her respiratory system) and PRE-EXISTING CONDITION IMPROVED (Helped with her asthma) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020F21A, 046A21A and 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma and Clotting disorder (Had blood clotting disorder called protein D deficiency and protein C). Concomitant products included ZAFIRLUKAST (ACCOLATE) for Asthma, RIVAROXABAN (XARELTO) and HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE HCTZ) for an unknown indication.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Sep-2021, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Had a positive reaction/it cleared up her lungs and all her respiratory system) and PRE-EXISTING CONDITION IMPROVED (Helped with her asthma). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (Had a positive reaction/it cleared up her lungs and all her respiratory system) and PRE-EXISTING CONDITION IMPROVED (Helped with her asthma) outcome was unknown.            Treatment information was not provided.  Patient stated that she had good side effects from receiving Moderna COVID-19 vaccine although it did not work for long term but for 8 weeks previously. Her asthma was good and then it went back down.   This case was linked to MOD-2021-306177, MOD-2021-306179 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis
Clinical narrative: sweating; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (sweating). At the time of the report, HYPERHIDROSIS (sweating) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No  Concomitant medications were provided. No Treatment medications were provided.
Sex: U
Vaccine: COVID19
Symptoms: Lymphadenopathy, Vaccination site erythema, Vaccination site mass
Clinical narrative: lump; lymph nodes swelling on neck; redness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (lump), LYMPHADENOPATHY (lymph nodes swelling on neck) and VACCINATION SITE ERYTHEMA (redness at injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (lump), LYMPHADENOPATHY (lymph nodes swelling on neck) and VACCINATION SITE ERYTHEMA (redness at injection site). At the time of the report, VACCINATION SITE MASS (lump) and LYMPHADENOPATHY (lymph nodes swelling on neck) outcome was unknown and VACCINATION SITE ERYTHEMA (redness at injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were provided. No treatment medication were provided.   This case was linked to MOD-2021-306401 (Patient Link).
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Interchange of vaccine products
Clinical narrative: He received the Johnson and Johnson vaccine back in March 2021. He then received a dose of the Moderna covid-19 vaccine by intramuscular injection to the left shoulder or upper arm on 2JUL2021; He received the Johnson and Johnson vaccine back in March 2021. He then received a dose of the Moderna covid-19 vaccine by intramuscular injection to the left shoulder or upper arm on 2JUL2021; This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (He received the Johnson and Johnson vaccine back in March 2021. He then received a dose of the Moderna covid-19 vaccine by intramuscular injection to the left shoulder or upper arm on 2JUL2021) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (He received the Johnson and Johnson vaccine back in March 2021. He then received a dose of the Moderna covid-19 vaccine by intramuscular injection to the left shoulder or upper arm on 2JUL2021) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: COVID-19 VACCINE (He received the Johnson and Johnson vaccine back in March 2021) in March 2021.    On 02-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jul-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (He received the Johnson and Johnson vaccine back in March 2021. He then received a dose of the Moderna covid-19 vaccine by intramuscular injection to the left shoulder or upper arm on 2JUL2021) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (He received the Johnson and Johnson vaccine back in March 2021. He then received a dose of the Moderna covid-19 vaccine by intramuscular injection to the left shoulder or upper arm on 2JUL2021). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (He received the Johnson and Johnson vaccine back in March 2021. He then received a dose of the Moderna covid-19 vaccine by intramuscular injection to the left shoulder or upper arm on 2JUL2021) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (He received the Johnson and Johnson vaccine back in March 2021. He then received a dose of the Moderna covid-19 vaccine by intramuscular injection to the left shoulder or upper arm on 2JUL2021) outcome was unknown.            No concomitant medication information was provided.  No treatment medication information was provided.  Patient received a dose of the Moderna covid-19 vaccine to the left shoulder or upper arm. He had talked to his doctor about receiving either the Moderna or Pfizer vaccine before receiving the first dose. It had been over 60 days since he received his first dose of the Moderna covid-19 vaccine.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: she even had the same reaction when she received the first two doses of the Moderna/It clears up her lungs/her asthma was good/helps with her asthma/had a positive reaction/clears up all her respiratory system; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (she even had the same reaction when she received the first two doses of the Moderna/It clears up her lungs/her asthma was good/helps with her asthma/had a positive reaction/clears up all her respiratory system) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Protein deficiency (Patient had a blood clotting disorder called Protein D deficiency and protein C.) and Asthma. Concomitant products included ZAFIRLUKAST (ACCOLATE) for Asthma, RIVAROXABAN (XARELTO) and HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE HCTZ) for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (she even had the same reaction when she received the first two doses of the Moderna/It clears up her lungs/her asthma was good/helps with her asthma/had a positive reaction/clears up all her respiratory system). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (she even had the same reaction when she received the first two doses of the Moderna/It clears up her lungs/her asthma was good/helps with her asthma/had a positive reaction/clears up all her respiratory system) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.   This case was linked to MOD-2021-306161, MOD-2021-306179 (Patient Link).
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: she even had the same reaction when she received the first two doses of the Moderna/It clears out her lungs/her asthma was good, then it goes back down; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (she even had the same reaction when she received the first two doses of the Moderna/It clears out her lungs/her asthma was good, then it goes back down) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020F21A, 022M20A and 046A21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma and Protein deficiency (Protein D and C deficiency). Concomitant products included ZAFIRLUKAST (ACCOLATE) for Asthma, RIVAROXABAN (XARELTO) and HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE HCTZ) for an unknown indication.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (she even had the same reaction when she received the first two doses of the Moderna/It clears out her lungs/her asthma was good, then it goes back down). On 01-Sep-2021, THERAPEUTIC RESPONSE UNEXPECTED (she even had the same reaction when she received the first two doses of the Moderna/It clears out her lungs/her asthma was good, then it goes back down) had resolved.            Treatment information was not reported  It was reported that patient is asthmatic and she just received the booster shot and had a positive reaction from it.   This case was linked to MOD-2021-306161, MOD-2021-306177 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: administered an expired moderna vaccine to a patient; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered an expired moderna vaccine to a patient) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered an expired moderna vaccine to a patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered an expired moderna vaccine to a patient) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitants were provided. No treatment reported.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Overdose
Clinical narrative: administered 1 ml of the Moderna COVID-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of OVERDOSE (administered 1 ml of the Moderna COVID-19 vaccine) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 milliliter. On an unknown date, the patient experienced OVERDOSE (administered 1 ml of the Moderna COVID-19 vaccine). At the time of the report, OVERDOSE (administered 1 ml of the Moderna COVID-19 vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Overdose
Clinical narrative: administered 1 ml of the Moderna COVID-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of OVERDOSE (administered 1 ml of the Moderna COVID-19 vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 ml. On an unknown date, the patient experienced OVERDOSE (administered 1 ml of the Moderna COVID-19 vaccine). At the time of the report, OVERDOSE (administered 1 ml of the Moderna COVID-19 vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant drugs were reported.  No Treatment information  were reported.
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Lymphadenopathy, Vaccination site pain
Clinical narrative: Sore arm (left arm) in deltoid and under arm; Sore arm (left arm) in deltoid and under arm; lymph nodes swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm (left arm) in deltoid and under arm), AXILLARY PAIN (Sore arm (left arm) in deltoid and under arm) and LYMPHADENOPATHY (lymph nodes swollen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Aug-2021, the patient experienced VACCINATION SITE PAIN (Sore arm (left arm) in deltoid and under arm), AXILLARY PAIN (Sore arm (left arm) in deltoid and under arm) and LYMPHADENOPATHY (lymph nodes swollen). At the time of the report, VACCINATION SITE PAIN (Sore arm (left arm) in deltoid and under arm), AXILLARY PAIN (Sore arm (left arm) in deltoid and under arm) and LYMPHADENOPATHY (lymph nodes swollen) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were reported. On an unknown date the patient had an magnetic resonance imaging (MRI) that found swollen lymph nodes. No treatment information was reported.   This case was linked to MOD-2021-306330 (Patient Link).
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Blepharospasm, Induration, Joint swelling, Peripheral swelling
Clinical narrative: Right arm has been swollen/swollen for over 4 months; It is hard; Eyelid twitching about 2 months after the shot; Balance has been off; Swollen from above my wrist all the way up to my shoulder; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Right arm has been swollen/swollen for over 4 months), INDURATION (It is hard), BLEPHAROSPASM (Eyelid twitching about 2 months after the shot), BALANCE DISORDER (Balance has been off) and JOINT SWELLING (Swollen from above my wrist all the way up to my shoulder) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 032M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Right arm has been swollen/swollen for over 4 months), INDURATION (It is hard), BLEPHAROSPASM (Eyelid twitching about 2 months after the shot), BALANCE DISORDER (Balance has been off) and JOINT SWELLING (Swollen from above my wrist all the way up to my shoulder). At the time of the report, PERIPHERAL SWELLING (Right arm has been swollen/swollen for over 4 months), INDURATION (It is hard), BLEPHAROSPASM (Eyelid twitching about 2 months after the shot), BALANCE DISORDER (Balance has been off) and JOINT SWELLING (Swollen from above my wrist all the way up to my shoulder) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details were provided. No treatment information was mentioned.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain, Pyrexia, Somnolence
Clinical narrative: drowsy; sharp pain for 2 seconds; fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (drowsy), PAIN (sharp pain for 2 seconds), PYREXIA (fever) and HEADACHE (headache) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 062E21 and 088D214) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy.   On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Sep-2021, the patient experienced SOMNOLENCE (drowsy), PAIN (sharp pain for 2 seconds), PYREXIA (fever) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, SOMNOLENCE (drowsy), PAIN (sharp pain for 2 seconds), PYREXIA (fever) and HEADACHE (headache) was resolving.            No relevant concomitant medications were reported.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: "covid arm"/REACTION; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION ("covid arm"/REACTION) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 3005287 and 3004225) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Aug-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE REACTION ("covid arm"/REACTION). At the time of the report, VACCINATION SITE REACTION ("covid arm"/REACTION) outcome was unknown.            No concomitant medications provided. No treatment medications provided.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: has a fever in it; started to itch; spreaded like a rash; started to swell/swollen for the past three days; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (started to itch), VACCINATION SITE RASH (spreaded like a rash), VACCINATION SITE SWELLING (started to swell/swollen for the past three days) and PYREXIA (has a fever in it) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0G2B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Aug-2021, the patient experienced VACCINATION SITE PRURITUS (started to itch), VACCINATION SITE RASH (spreaded like a rash) and VACCINATION SITE SWELLING (started to swell/swollen for the past three days). On an unknown date, the patient experienced PYREXIA (has a fever in it). At the time of the report, VACCINATION SITE PRURITUS (started to itch), VACCINATION SITE RASH (spreaded like a rash), VACCINATION SITE SWELLING (started to swell/swollen for the past three days) and PYREXIA (has a fever in it) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Took acetaminophen and used an ice pack.  Relevant concomitant medications were not provided by the reporter.